{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:31:10Z","timestamp":1772757070753,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["oto.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.otc.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T03:31:17Z","timestamp":1479958277000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Evan S.","family":"Walgama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.otc.2016.08.007_bib1","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/lary.23979","article-title":"Subclassification of chronic rhinosinusitis","volume":"123","author":"Han","year":"2013","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"23","key":"10.1016\/j.otc.2016.08.007_bib3","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"issue":"6","key":"10.1016\/j.otc.2016.08.007_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0091-6749(83)90440-2","article-title":"Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration","volume":"71","author":"Lumry","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2016.08.007_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","article-title":"Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes","volume":"98","author":"Stevenson","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2016.08.007_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(84)90361-0","article-title":"Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin","volume":"73","author":"Stevenson","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"10.1016\/j.otc.2016.08.007_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","article-title":"Long-term effects of aspirin desensitization\u2013treatment for aspirin-sensitive rhinosinusitis-asthma","volume":"85","author":"Sweet","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otc.2016.08.007_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cea.12359","article-title":"Aspirin-intolerant asthma in the population: prevalence and important determinants","volume":"45","author":"Eriksson","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.otc.2016.08.007_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/CRIAI:24:2:137","article-title":"Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs","volume":"24","author":"Berkes","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.otc.2016.08.007_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2016.08.007_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study","volume":"134","author":"\u015awierczy\u0144ska-Krepa","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib17","first-page":"20","article-title":"Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls","volume":"38","author":"Micheletto","year":"2006","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"3 Pt 1","key":"10.1016\/j.otc.2016.08.007_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.otc.2016.08.007_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaci.2015.05.041","article-title":"Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Mitsui","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.otc.2016.08.007_bib21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2015.02.005","article-title":"Platelets in patients with aspirin-exacerbated respiratory disease","volume":"135","author":"Laidlaw","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.otc.2016.08.007_bib22","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.otc.2016.08.007_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.otc.2016.08.007_bib24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"Perez-Novo","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2016.08.007_bib25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2013.05.008","article-title":"Prominent role of IFN-gamma in patients with aspirin-exacerbated respiratory disease","volume":"132","author":"Steinke","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2500\/ajra.2015.29.4123","article-title":"Factors driving the aspirin exacerbated respiratory disease phenotype","volume":"29","author":"Steinke","year":"2015","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.otc.2016.08.007_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.otc.2016.08.007_bib28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/014556130708600715","article-title":"The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery","volume":"86","author":"Kim","year":"2007","journal-title":"Ear Nose Throat J"},{"issue":"5 Suppl","key":"10.1016\/j.otc.2016.08.007_bib29","first-page":"S94","article-title":"Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007","volume":"120","author":"National Asthma","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2016.08.007_bib30","first-page":"817910","article-title":"Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination","volume":"2012","author":"Graefe","year":"2012","journal-title":"J\u00a0Allergy"},{"issue":"7","key":"10.1016\/j.otc.2016.08.007_bib31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/MLG.0b013e318170af1e","article-title":"Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma?","volume":"118","author":"Awad","year":"2008","journal-title":"Laryngoscope"},{"issue":"2 Suppl","key":"10.1016\/j.otc.2016.08.007_bib32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599815572097","article-title":"Clinical practice guideline (update): adult sinusitis","volume":"152","author":"Rosenfeld","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.otc.2016.08.007_bib33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1753465811427577","article-title":"Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps","volume":"6","author":"Vuralkan","year":"2012","journal-title":"Ther Adv Respir Dis"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.otohns.2008.07.010","article-title":"Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis","volume":"139","author":"Stewart","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.otc.2016.08.007_bib36","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/lary.24477","article-title":"Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis?","volume":"124","author":"Smith","year":"2014","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaci.2009.08.030","article-title":"Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis","volume":"124","author":"Di Capite","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4 Pt 1","key":"10.1016\/j.otc.2016.08.007_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics","volume":"157","author":"Dahlen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","article-title":"Oral steroids and doxycycline: two different approaches to treat nasal polyps","volume":"125","author":"Van Zele","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2016.08.007_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000353976","article-title":"Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease","volume":"162","author":"Yoo","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.otc.2016.08.007_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaip.2015.01.012","article-title":"Omalizumab in the treatment of aspirin-exacerbated respiratory disease","volume":"3","author":"Bergmann","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.anai.2013.01.024","article-title":"Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma","volume":"110","author":"Tajiri","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2500\/ajra.2015.29.4223","article-title":"Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: risks and benefits","volume":"29","author":"Poetker","year":"2015","journal-title":"Am J Rhinol Allergy"},{"issue":"12","key":"10.1016\/j.otc.2016.08.007_bib45","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.rmed.2013.09.007","article-title":"Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes","volume":"107","author":"Aasbjerg","year":"2013","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib46","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/lary.23721","article-title":"Eosinophilic rhinosinusitis is not a disease of ostiomeatal occlusion","volume":"123","author":"Snidvongs","year":"2013","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.otc.2016.08.007_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2500\/ajr.2008.22.3148","article-title":"Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients","volume":"22","author":"Awad","year":"2008","journal-title":"Am J Rhinol"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","article-title":"Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis","volume":"60","author":"Szczeklik","year":"1977","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","article-title":"Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma","volume":"84","author":"Settipane","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.otc.2016.08.007_bib50","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1378\/chest.121.6.1812","article-title":"Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma","volume":"121","author":"Martin-Garcia","year":"2002","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.otc.2016.08.007_bib51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.otc.2016.08.007_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11882-009-0023-4","article-title":"Aspirin sensitivity and desensitization for asthma and sinusitis","volume":"9","author":"Stevenson","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.otc.2016.08.007_bib53","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","article-title":"Effect of leukotriene modifier drugs on the safety of oral aspirin challenges","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.otc.2016.08.007_bib54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2013.34.3670","article-title":"The clinical dilemma of \u201csilent desensitization\u201d in aspirin-exacerbated respiratory disease","volume":"34","author":"White","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"10.1016\/j.otc.2016.08.007_bib55","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaip.2015.06.013","article-title":"An hourly dose-escalation desensitization protocol for aspirin-exacerbated respiratory disease","volume":"3","author":"Chen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otc.2016.08.007_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anai.2010.05.020","article-title":"Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease","volume":"105","author":"Lee","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.otc.2016.08.007_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","article-title":"Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease","volume":"119","author":"Lee","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2016.08.007_bib58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0194599814545750","article-title":"Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease","volume":"151","author":"Cho","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1036","key":"10.1016\/j.otc.2016.08.007_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/postgradmedj-2011-130291","article-title":"Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management","volume":"88","author":"Shah","year":"2012","journal-title":"Postgrad Med J"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666516301657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666516301657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T22:40:34Z","timestamp":1568587234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666516301657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0030666516301657"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2016.08.007","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin-Exacerbated Respiratory Disease","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}